Great West Life Assurance CO Esperion Therapeutics, Inc. Transaction History

Great West Life Assurance CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$1.46 - $7.3 $29,997 - $149,985	20,546 Added 683.5%	23,552 $38,000
Q4 2022 Feb 10, 2023	BUY	$5.09 - $8.5 $15,300 - $25,551	3,006 New	3,006 $19,000
Q4 2021 Feb 14, 2022	SELL	$4.81 - $11.92 $7,984 - $19,787	-1,660 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$31.18 - $52.71 $6.55 Million - $11.1 Million	-210,000 Reduced 99.22%	1,660 $61,000
Q3 2020 Nov 13, 2020	BUY	$31.18 - $52.71 $6.55 Million - $11.1 Million	210,000 Added 12650.6%	211,660 $7.87 Million
Q3 2019 Oct 25, 2019	SELL	$34.47 - $47.53 $50,601 - $69,774	-1,468 Reduced 46.93%	1,660 $61,000
Q4 2017 Feb 09, 2018	BUY	$43.47 - $67.43 $79,463 - $123,262	1,828 Added 140.62%	3,128 $206,000
Q3 2017 Nov 09, 2017	BUY	$43.8 - $52.77 $56,939 - $68,601	1,300	1,300 $65,000

209

129M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $140M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.